CEFIACT 50* DRY SYRUP
APPLICATION
Prime choice for switch therapy owing to its very good efficacy and safety profile
Cefixime is more efficacious than Arnoxicillin in treating H.influenzae otitis media and should be preferred when H.influenzae is the suspected etiologic agent
Cefixime is superior to Trimethorpim/sulpha-methoxazole in the treatment of suspected Shigellosis in cases high rate of resistant to TMP-SMX
Effective in
Pneumonia
Bronchitis
Typhoid Fever
Sinusitis
UTI
Otitis Media
Highly stable in the presence of beta-lactamase enzymes
Effective and safe oral antibiotic for the treatment of acute respiratory tract infections